BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
BASEL, Switzerland, March 05, 2026 (GLOBE NEWSWIRE) -- BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing o...